Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization.

< BACK TO ARCHIVE


2020 Jul 03


Am J Perinatol


http://www.ncbi.nlm.nih.gov/pubmed/32620022?dopt=Abstract

Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization.

Authors

Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization.
Fassett MJ, Lurvey LD, Yasumura L, Nguyen M, Colli JJ, Volodarskiy M, Gullett JC, Braun D, Fong A, Trivedi N, Bruxvoort K, Chiu V, Getahun D
Am J Perinatol. 2020 Jul 03.
PMID: 32620022.

Abstract

 The coronavirus disease 2019 (COVID-19) pandemic has created a need for data regarding the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnant women. After implementing universal screening for COVID-19 in women admitted for delivery, we sought to describe the characteristics of COVID-19 in this large cohort of women.
Read This Paper